Novaquin

RSS

meloxicam

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Novaquin. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Novaquin.

For practical information about using Novaquin, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 28/01/2022

Authorisation details

Product details
Name
Novaquin
Agency product number
EMEA/V/C/003866
Active substance
meloxicam
International non-proprietary name (INN) or common name
meloxicam
Species
Horses
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AC06
Publication details
Marketing-authorisation holder
Le Vet Beheer B.V. 
Revision
4
Date of issue of marketing authorisation valid throughout the European Union
08/09/2015
Contact address
Le Vet Beheer B.V.
Wilgenweg 7
3421 TV Oudewater
The Netherlands

Product information

27/01/2022 Novaquin - EMEA/V/C/003866 - IG1436

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Oxicams

Therapeutic indication

Alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders in horses.

Assessment history

How useful was this page?

Add your rating